In this current study, based on the results of the cell proliferation assay and by the measurement of caspase-3-activity, we showed that shikonin induced apoptosis in CAKI-2 and A-498 renal cancer cells in vitro. The gene discussed is CASP3; the disease is renal carcinoma.